Ropeginterferon alfa-2b-njft (Subcutaneous)
Medically reviewed by Drugs.com. Last updated on Dec 28, 2021.
Risk of Serious DisordersInterferon alfa products may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders. Patients should be monitored closely with periodic clinical and laboratory evaluations. Therapy should be withdrawn in patients with persistently severe or worsening signs or symptoms of these conditions. In many, but not all cases, these disorders resolve after stopping therapy .
Commonly used brand name(s)
In the U.S.
- BESREMi
Available Dosage Forms:
- Solution
Pharmacologic Class: Ropeginterferon Alfa-2b
Uses for ropeginterferon alfa-2b-njft
Ropeginterferon alfa-2b-njft injection is used to treat polycythemia vera.
Ropeginterferon alfa-2b-njft is available only with your doctor's prescription.
Before using ropeginterferon alfa-2b-njft
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For ropeginterferon alfa-2b-njft, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to ropeginterferon alfa-2b-njft or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies have not been performed on the relationship of age to the effects of ropeginterferon alfa-2b-njft injection in the pediatric population. Safety and efficacy have not been established.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of ropeginterferon alfa-2b-njft injection in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require caution and an adjustment in the dose for patients receiving ropeginterferon alfa-2b-njft.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking ropeginterferon alfa-2b-njft, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using ropeginterferon alfa-2b-njft with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Acepromazine
- Alfentanil
- Alprazolam
- Amobarbital..
